Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,000
Closed -$49.6K 116
2022
Q4
$49.6K Sell
4,000
-2,500
-38% -$43.9K 0.03% 78
2022
Q3
$134K Hold
6,500
0.06% 127
2022
Q2
$180K Sell
6,500
-500
-7% -$17.1K 0.05% 158
2022
Q1
$306K Sell
7,000
-1,000
-13% -$43.5K 0.12% 142
2021
Q4
$442K Buy
8,000
+1,300
+19% +$80.3K 0.12% 163
2021
Q3
$414K Sell
6,700
-12,300
-65% -$810K 0.12% 170
2021
Q2
$1.61M Buy
+19,000
New +$1.73M 0.4% 81
2021
Q1
Sell
-4,000
Closed -$233K 285
2020
Q4
$233K Buy
+4,000
New +$188K 0.07% 162
2020
Q1
Sell
-10,000
Closed -$274K 124
2019
Q4
$274K Buy
+10,000
New +$267K 0.12% 93
2019
Q3
Sell
-6,091
Closed -$175K 111
2019
Q2
$175K Buy
6,091
+1,091
+22% +$36.7K 0.06% 87
2019
Q1
$210K Buy
5,000
+3,000
+150% +$108K 0.11% 98
2018
Q4
$62K Buy
+2,000
New +$74.4K 0.11% 60

Other funds holding AFMD

MYDA Advisors's AFMD Position: Q1 2023 in Review

MYDA Advisors sold out of Affimed (AFMD) in Q1 2023, closing a stake of 4,000 shares — an estimated $49.6K sold.

MYDA Advisors first reported a position in AFMD in Q4 2018 and held it in 12 quarters. The position peaked at $1.61M in Q2 2021. 94 funds tracked by Wall St. Rank hold AFMD as of Q1 2023.

  • MYDA Advisors reported no remaining Affimed position as of Q1 2023 after selling out during the quarter.
  • MYDA Advisors sold 4,000 Affimed shares in Q1 2023, an estimated $49.6K.
  • MYDA Advisors first reported a position in Affimed in Q4 2018 and held it in 12 quarters.
  • MYDA Advisors's Affimed position peaked at $1.61M in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Affimed as of Q1 2023.

Based on MYDA Advisors's 13F filing for Q1 2023, filed 12 May 2023.